Among various plasma amyloid and tau markers, phosphorylated tau at threonine 217 (p-tau217) is one of the emerging tau markers that has repeatedly shown more promise than other p-tau isoforms as a marker of AD pathology. This evidence concerns the gene MAPT and Alzheimer disease.